Peyronie's disease: A review

Current Opinion in Urology

Volumn 13, Issue 5, 2003, Pages 417-422

  Briganti, Alberto ^a   Salonia, Andrea ^a   Deho, Federico ^a   Zanni, Giuseppe ^a   Rokkas, Konstantinos ^a   Rigatti, Patrizio ^a   Montorsi, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Peyronie's disease; Prevalence; Surgery; Treatment

Indexed keywords

ALPHA TOCOPHEROL; ALPHA2B INTERFERON; AMINOBENZOIC ACID; ANTIHISTAMINIC AGENT; COLCHICINE; COLLAGENASE; PROCARBAZINE; STEROID; SUPEROXIDE DISMUTASE; TAMOXIFEN; VERAPAMIL;

CLINICAL FEATURE; DIAGNOSTIC IMAGING; EXTRACORPOREAL LITHOTRIPSY; FREE SKIN GRAFT; HUMAN; IONTOPHORESIS; MALE GENITAL SYSTEM SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PENIS ERECTION; PENIS PROSTHESIS; PEYRONIE DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUNICA ALBUGINEA;

HUMANS; MALE; PENILE INDURATION;

EID: 0043263863     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200309000-00010     Document Type: Review

References (37)

1. Sommer F, Schwarzer U, Wassmer G, et al. Epidemiology of Peyronie's disease. Int J Impotence Res 2002; 14:379-383.
2. Hauck EW, Hackstein N, Vosshenrich R, et al. Diagnostic value of magnetic resonance imaging in Peyronie's disease: a comparison both with palpation and ultrasound in the evaluation of plaque for formation. Eur Urol 2003; 43:293-300.
3. Lindsay MB, Shain DM, Grambsch P, et al. The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J Urol 1991; 146:1007-1009.
4. Smith BH. Subclinical Peyronie's disease. Am J Clin Pathol 1969; 52:385-390.
5. Kadioglu A, Tefekli A, Erol B, et al. A retrospective review of 307 men with Peyronie's disease. J Urol 2002; 168:1075-1079.
6. Gholami SS, Gonzalez-Cadavid N, Lin CS, et al. Peyronie's disease: a review. J Urol 2003; 169:1234-1241.
7. Moreland RB, Nehra A. Pathophysiology of Peyronie's disease. Int J Impotence Res 2002; 14:406-410.
8. Leffell MS. Is there an immunogenetic basis for Peyronie's disease? J Urol 1997; 157:291-294.
9. Schiavino D, Sasso F, Nucera, et al. Immunologic findings in Peyronie's disease: a controlled study. Urology 1997; 50:105-106.
10. El-Sakka AI, Hassoba HM, Pillarisetty PJ, et al. Peyronie's disease is associated with an increase in transforming growth factor-[beta] protein expression. J Urol 1997; 158:1391-1394.
11. Bivilacqua TJ, Champion HC, Hellstrom WJG, Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease. Int J Impotence Res 2002; 14:345-352.
12. Gonzalez-Cadavid NF, Magee TR, Ferrini M, et al. Gene expression in Peyronie's disease. Int J Impotence Res 2002; 14:361-374.
13. Hauck EW, Hauptmann A, Schmelz, et al. Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie's disease. J Urol 2003; 169:369-372.
14. Lin CS, Lin G, Wang Z, et al. Upregulation of monocyte chemoattractant protien 1 and effects on transforming growth factor-beta 1 in Peyronie's disease. Biochem Biophys Res Commun 2002; 295:1014-1017.
15. Lue TF. Peyronie's disease: an anatomically-based hypothesis and beyond. Int J Impotence Res 2002; 14:411-413.
16. Pryor JP, Ralph DJ. Clinical presentation of Peyronie's disease. Int J Impotence Res 2002; 14:414-417.
17. Tefekli A, Kandirali E, Erol H, et al. Peyronie's disease in men under age 40: characteristics and outcome. Int J Impotence Res 2001; 13:18-23.
18. Erdogru T, Boz A, Koksal T, et al. Penile scintigraphy with Tc-99m-human immunoglobulin G: a novel method for distinguishing the unstable and stable phases of Peyronie's disease. BJU Int 2002; 90:703-706.
19. Mynderse LA, Monga M. Oral therapy for Peyronie's disease. Int J Impotence Res 2002; 14:340-344.
20. Pryor JP, Farrel CR. Controlled clinical trial of vitamin E in Peyronie's disease. Prog Reprod Biol Med 1983; 9:41-45.
21. Devine Jr CJ, Horton CE. Bent penis. Semin Urol 1987; 5:251-261.
22. Prieto Castro RM, Leva Vallejo ME, Reguiero Lopez JC, et al. Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease. BJU Int 2003; 91:522-524.
23. Manikandan R, Islam W, Srinivasan V, Evans CM. Evaluation of extracorporeal shock wave therapy in Peyronie's disease. Urology 2002; 60:795-799.
24. Lebret T, Loison G, Herve JM, et al. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (Siemens. Multiline). Urology 2002; 59:657-661.
25. Levine LA, Estrada CR. Intralesional verapamil for the treatment of Peyronie's disease: a review. Int J Impotence Res 2002; 14:324-328.
26. Cavallini G, Biagiotti G, Koverech A, Vitali G. Oral propionil-I-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease. BJU Int 2002; 89:895-900.
27. Lacy GL II, Adams DM, Hellstrom WJG. Intralesional interferon-alpha-2b for the treatment of Peyronie's disease. Int J Impotence Res 2002; 14:336-339.
28. Levine LA, Lenting EL. A surgical algorithm for the treatment of Peyronie's disease. J Urol 1997; 158:2149-2152.
29. Mulcahy JJ, Wilson SK. Management of Peyronie's disease with penile prosthesis. Int J Impotence Res 2002; 14:384-388.
30. Gholami SS, Lue TF. Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol 2002; 167:2066-2069.
31. Hatzichristou DG, Hatzimouratidis K, Apostolidis A, et al. Corporoplasty using tunica albuginea free grafts for penile curvature: surgical technique and long term results. J Urol 2002; 167:1367-1370.
32. Lahme S, Gotz T, Bichler KH. Collagen fleece for defect coverage following plaque excision in patients with Peyronie's disease. Eur Urol 2002; 41:401-405.
33. Sampaio JS, Fonseca J, Passarinho A, et al. Peyronie's disease: surgical correction of 40 patients with relaxing incision and duramater graft. Eur Urol 2002; 41:551-555.
34. Egydio PH, Lucon AM, Arap S. Treatment of Peyronie's disease by incomplete circumferential incision of the tunica albuginea and plaque with bovine pericardium graft. Urology 2002; 59:570-574.
35. Hauck EW, Bschleipfer T, Diemer T, et al. Long-term results of plaque thinning with carbide burs, small incisions and venous grafting for correcting complex penile curvature in Peyronie's disease: poor results for an ideal approach. J Urol 2002; 167:2070-2073.
36. Adeniyi AA, Goorney SR, Pryor JP, Ralph DJ. The Lue procedure: an analysis of the outcome in Peyronie's disease. BJU Int 2002; 89:404-408.
37. Backhaus BO, Muller SC, Albers P. Corporoplasty for advanced Peyronie's disease using venous and/or dermis patch grafting: new surgical technique and long-term patients satisfaction. J Urol 2003; 169:981-984.